4Filing Date: Mar 23, 2026

Eog Resources

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0000821189-26-000071
Total Value$1.66M
Trades5
Insiders1

Transaction Details

Janssen Ann D.
EVP & Chief Financial Officer·Direct
Exercise · Acquire
Common Stock
Shares+9.37K
Price$37.44
Total Value$350.6K
Shares Owned After109.61K
Transaction DateMar 19, 2026
Footnotes ▸

The SARs granted became exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 28, 2020 date of grant. The SARs granted became fully exercisable on September 28, 2023.

Janssen Ann D.
EVP & Chief Financial Officer·Direct
Tax W/H · Dispose
Common Stock
Shares-2.70K
Price$140.06
Total Value$378.1K
Shares Owned After104.41K
Transaction DateMar 19, 2026
Janssen Ann D.
EVP & Chief Financial Officer·Direct
Sell · Dispose
Common Stock
Shares-4.16K
Price$140.04
Total Value$582.7K
Shares Owned After100.25K
Transaction DateMar 19, 2026
Janssen Ann D.
EVP & Chief Financial Officer·Direct
Exercise · Dispose
Stock Appreciation RightsDerivative
Shares-9.37K
Price$0.00
Total Value$0
Shares Owned After0
Transaction DateMar 19, 2026
ExpiresSep 28, 2027
Footnotes ▸

The SARs granted became exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 28, 2020 date of grant. The SARs granted became fully exercisable on September 28, 2023.

Janssen Ann D.
EVP & Chief Financial Officer·Direct
Dispose · Dispose
Common Stock
Shares-2.50K
Price$140.06
Total Value$350.7K
Shares Owned After107.11K
Transaction DateMar 19, 2026

Post-Transaction Holdings

Janssen Ann D. · EVP & Chief Financial Officer
SecuritySharesChange
Common Stock109.61K-
Stock Appreciation Rights0-9.37K (-100.00%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-03-19 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: EOG RESOURCES INC (EOG) CIK: 0000821189 --- Reporting Owner --- Name: Janssen Ann D. CIK: 0001501126 Role: Officer (EVP & Chief Financial Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-03-19 | Code: M (Exercise of derivative) Shares: +9,365 | Price: $37.44 Total Value: $350,625.60 Shares Owned After: 109,611.3831 | Ownership: D (Direct) Footnotes: [F1] The SARs granted became exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 28, 2020 date of grant. The SARs granted became fully exercisable on September 28, 2023. [Transaction #2] Security: Common Stock Date: 2026-03-19 | Code: D (Sale to issuer) Shares: -2,504 | Price: $140.06 Total Value: $350,697.72 Shares Owned After: 107,107.3831 | Ownership: D (Direct) [Transaction #3] Security: Common Stock Date: 2026-03-19 | Code: F (Payment of exercise/tax) Shares: -2,700 | Price: $140.06 Total Value: $378,148.50 Shares Owned After: 104,407.3831 | Ownership: D (Direct) [Transaction #4] Security: Common Stock Date: 2026-03-19 | Code: S (Open market sale) Shares: -4,161 | Price: $140.04 Total Value: $582,706.44 Shares Owned After: 100,246.3831 | Ownership: D (Direct) --- Derivative Transactions --- [Transaction #1] Security: Stock Appreciation Rights Date: 2026-03-19 | Code: M (Exercise of derivative) Shares: -9,365 | Price: $0.00 Exercisable: N/A | Expires: 2027-09-28 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F1] The SARs granted became exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 28, 2020 date of grant. The SARs granted became fully exercisable on September 28, 2023. --- Footnotes (Complete Index) --- F1: The SARs granted became exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 28, 2020 date of grant. The SARs granted became fully exercisable on September 28, 2023. --- Signature --- /s/ Michael E. Montifar, attorney-in-fact for Ann D. Janssen (2026-03-23)

keid analysis is for reference only and does not constitute investment advice.